2023 Form 5500 filing — Teva Pharmaceuticals Usa, Inc. Supplemental Unemployment Benefit Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241008101829NAL0017394433001) for Teva Pharmaceuticals Usa, Inc. Supplemental Unemployment Benefit Plan, reported by Teva Pharmaceuticals Usa, Inc. under EIN 22-1734359 and plan number 510. It reports 5,181 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241008101829NAL0017394433001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Teva Pharmaceuticals Usa, Inc.
- EIN
- 22-1734359
- Plan number
- 510
- Location
- Parsippany, NJ
- Participants
- 5,181
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $791
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $791
- Employer contributions
- $4,572,772
- Total income / additions
- $4,574,012
- Benefits paid
- $4,574,272
- Administrative expenses
- $5,000
- Total expenses
- $4,579,272
- Net increase / (decrease)
- -$5,260
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Bank Of America, Na | NONE | $5,000 | not reported in the loaded dataset |